Tip: Index histories & All-time highs

Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Tue, 28.09.2021       Schloss Wachenheim AG
First Berlin Equity Research GmbH DE0007229007

First Berlin Equity Research hat ein Research Update zu Schloss Wachenheim AG (ISIN: DE0007229007) veröffentlicht. Analyst Simon Scholes bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 22,00 auf EUR 25,00. Zusammenfassung: Die endgültigen Ergebnisse von Schloss Wachenheim für 2020/21 entsprachen den vorl&a [ … ]
Technical analysis
To the publication
Mon, 27.09.2021       UmweltBank AG
GBC AG DE0005570808

H1 2021: Business volume significantly increased, forecasts and target price slightly raised, rating reduced to HOLD after strong share price performance The increase in business volume, i.e. total assets plus contingent liabilities and other obligations, forecast by the Umweltbank management was impressively confirmed with the presentation of t [ … ]
Technical analysis
To the publication
Thu, 23.09.2021       Aroundtown SE
First Berlin Equity Research GmbH LU1673108939

First Berlin Equity Research hat ein Research Update zu Aroundtown SA (ISIN: LU1673108939) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 8,60. Zusammenfassung: Aroundtown startete ein Barangebot für mehrere Bonds in seinem Anleihenportfolio. Die Anleihen lauten auf EUR [ … ]
Technical analysis Trade The News (TTN)
To the publication
Thu, 23.09.2021       Formycon
First Berlin Equity Research GmbH DE000A1EWVY8

First Berlin Equity Research hat ein Research Update zu Formycon AG (ISIN: DE000A1EWVY8) veröffentlicht. Analyst Simon Scholes stuft die Aktie auf BUY herauf und bestätigt sein Kursziel von EUR 78,00. Zusammenfassung: Die Umsatzerlöse in H1/21 in Höhe von €20,3 Mio. (FBe €21,0 Mio.; H1/20: €16,5 Mio.) lagen nah [ … ]
Technical analysis
To the publication
Mon, 20.09.2021       MPH Health Care AG
First Berlin Equity Research GmbH DE000A289V03

First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 75,00. Zusammenfassung: Der Sechsmonatsbericht spiegelte die Kurserholung der Beteiligungen seit Jahresbeginn wider, angeführt  [ … ]
Technical analysis
To the publication
Mon, 20.09.2021       wallstreet:online AG
GBC AG DE000A2GS609

HY1 2021: Continuation of dynamic customer and revenue growth; Significant profitability increase expected in HY2; GBC estimates and price target confirmed Sales development HY1 2021 wallstreet:online AG (wallstreet:online) was able to continue its dynamic growth course in the first six months of the current financial year. Compared to the sam [ … ]
Technical analysis
To the publication
Fri, 17.09.2021       CR Capital AG
First Berlin Equity Research GmbH DE000A2GS625

First Berlin Equity Research hat ein Research Update zu CR Capital AG (ISIN: DE000A2GS625) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 37,00 auf EUR 58,00. Zusammenfassung: Eine Reihe von Branchen und Sektoren haben in der Pandemie zu kämpfen, aber die Aussichten von CR  [ … ]
Technical analysis
To the publication
Mon, 13.09.2021       Cardiol Therapeutics Inc.
GBC AG CA14161Y2006

Die FDA hat die Freigabe zur Durchführung der klinischen Phase-II-Studie für CardiolRX(TM) bei akute Myokarditis erteilt. Dr. Guillermo Torre-Amione wurde zum neuen Vorsitzenden ernannt Die Aktien der Cardiol Therapeutics sind nun auch an der NASDAQ gelistet. Am 24. August erhielt Cardiol Therapeutics von der FDA die Freigabe des IND-A [ … ]
Technical analysis
To the publication
Thu, 09.09.2021       Cardiol Therapeutics
GBC AG CA14161Y2006

On August 24th, Cardiol Therapeutics received FDA Clearance of Investigational New Drug (IND) Application for Phase II Clinical Trial of CardiolRx(TM) for Acute Myocarditis. Phase II trial details The company's Investigational New Drug (IND) application approval allows Cardiol Therapeutics to commence a Phase II, multi-center, double-blind, ra [ … ]
Technical analysis
To the publication
Wed, 08.09.2021       HAEMATO AG
First Berlin Equity Research GmbH DE000A289VV1

First Berlin Equity Research hat ein Research Update zu HAEMATO AG (ISIN: DE000A289VV1) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 49,00 auf EUR 50,00. Zusammenfassung: Der Sechsmonatsbericht zeigte eine starke Umsatz- und Ergebnissteigerung, die FBe bei weitem übertraf [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Saturday, 23.11.2024, Calendar Week 47, 328th day of the year, 38 days remaining until EoY.